Konstantin Zoeller, MSc Novartis

Konstantin Zoeller joined Novartis Pharma AG in 2008. His initial focus was on process development R&D to develop purification processes for biologicals supporting early and late phase programs.

Since 2009, he has focused on viral clearance and, at present, is responsible for early and late phase viral clearance studies and providing scientific advice on viral safety.

Mr. Zoeller studied Biotechnology at the University of Applied Sciences in Mannheim, Germany and earned his MSc in Biotechnology in manufacturing viral vectors for gene therapy at the German Cancer Research Center in Heidelberg.